Apr 17 |
It’s Not Just Weight Loss. Eli Lilly Obesity Drug Works on This Chronic Condition.
|
Apr 17 |
Eli Lilly obesity therapy succeeds in late-stage trials for sleep disorder
|
Apr 17 |
UPDATE 3-Lilly's weight-loss drug reduces sleep apnea severity in late-stage studies
|
Apr 17 |
Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity
|
Apr 16 |
Eli Lilly (LLY) Stock Dips While Market Gains: Key Facts
|
Apr 16 |
Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement
|
Apr 15 |
Jim Cramer is Recommending These 10 Stocks in April
|
Apr 15 |
More than 250 websites selling fake weight-loss drugs reported by anti-counterfeit firm
|
Apr 13 |
Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024
|
Apr 13 |
3 Magnificent Stocks That Could Double or More by 2030
|